ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Clinical Trial Participants Sue Duke University, Potti, Nevins and Others for Causing Harm

September 9, 2011

Lateral Radiation Therapy Results in Regional Control In Advanced Tonsil Cancer

February 28, 2014

In Brief: William Blot, Michael Grever, Others To Leave NCI; RAC Approves Naked DNA Vaccine Trial

June 17, 1994

Protocols Approved By NCI During January 2004

February 27, 2004

In Brief: AACR To Have Fur Symposia, Including One With ASCO; McConnell Names TRTP Director

March 21, 1986

ORI Finds Misconduct By CIT Professor

August 4, 1995